The delay is at least the second such move by the USDA, the agency said in a press release, after it made a similar decision ...
The biotech reported progress on its lead molecule and out-licensed two candidates, amid cash constraints and a potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback